Clinical Evaluation of the GLYDe Dressing for Post-surgical Incision Care
NCT ID: NCT00766727
Last Updated: 2020-12-14
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2008-10-31
2010-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of a Novel Silicone Dressing to Minimize Scar Formation
NCT01399099
Abdominal Scar Improvement in Microsurgical Breast Reconstruction
NCT05377723
Investigation of a Novel Silicone Dressing to Maximize the Outcomes of Scar Revision Procedures (IMPROVE)
NCT01430130
NovoX®Cup as Primary Dressing After Breast Reduction
NCT06420323
Activated Carbon Interphase Effect on Surgical Incisions vs.Two Common Wound Dressings
NCT04038671
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GLYDe Dressing
Investigational Dressing
GLYDe Dressing
Wound dressing intended to minimize scar formation
Standard of Care
Standard of care comparator
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GLYDe Dressing
Wound dressing intended to minimize scar formation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* subjects with known adverse reactions to steri-strips, medical tapes or adhesives
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Neodyne Biosciences, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Longaker, MD
Role: STUDY_DIRECTOR
Neodyne Biosciences, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Josh Korman, MD
Mountain View, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gurtner GC, Dauskardt RH, Wong VW, Bhatt KA, Wu K, Vial IN, Padois K, Korman JM, Longaker MT. Improving cutaneous scar formation by controlling the mechanical environment: large animal and phase I studies. Ann Surg. 2011 Aug;254(2):217-25. doi: 10.1097/SLA.0b013e318220b159.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CA001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.